17-80198529-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001366385.1(CARD14):​c.1789C>T​(p.Arg597Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00192 in 1,613,262 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R597L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.010 ( 19 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 31 hom. )

Consequence

CARD14
NM_001366385.1 missense

Scores

1
6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.928

Publications

2 publications found
Variant links:
Genes affected
CARD14 (HGNC:16446): (caspase recruitment domain family member 14) This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
CARD14 Gene-Disease associations (from GenCC):
  • familial pityriasis rubra pilaris
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • psoriasis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062526762).
BP6
Variant 17-80198529-C-T is Benign according to our data. Variant chr17-80198529-C-T is described in ClinVar as Benign. ClinVar VariationId is 458090.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0103 (1576/152376) while in subpopulation AFR AF = 0.0361 (1502/41584). AF 95% confidence interval is 0.0346. There are 19 homozygotes in GnomAd4. There are 764 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1576 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD14NM_001366385.1 linkc.1789C>T p.Arg597Trp missense_variant Exon 16 of 24 ENST00000648509.2 NP_001353314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD14ENST00000648509.2 linkc.1789C>T p.Arg597Trp missense_variant Exon 16 of 24 NM_001366385.1 ENSP00000498071.1

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1575
AN:
152258
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00287
AC:
716
AN:
249616
AF XY:
0.00220
show subpopulations
Gnomad AFR exome
AF:
0.0381
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000801
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00104
AC:
1524
AN:
1460886
Hom.:
31
Cov.:
32
AF XY:
0.000901
AC XY:
655
AN XY:
726776
show subpopulations
African (AFR)
AF:
0.0366
AC:
1226
AN:
33476
American (AMR)
AF:
0.00212
AC:
95
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86242
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52610
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000522
AC:
58
AN:
1111880
Other (OTH)
AF:
0.00214
AC:
129
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
87
174
260
347
434
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0103
AC:
1576
AN:
152376
Hom.:
19
Cov.:
32
AF XY:
0.0103
AC XY:
764
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.0361
AC:
1502
AN:
41584
American (AMR)
AF:
0.00340
AC:
52
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68044
Other (OTH)
AF:
0.00993
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
80
160
240
320
400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00464
Hom.:
31
Bravo
AF:
0.0124
ESP6500AA
AF:
0.0363
AC:
160
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00340
AC:
413
Asia WGS
AF:
0.00231
AC:
9
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CARD14: BP4, BS1, BS2 -

Pityriasis rubra pilaris;C1864497:Psoriasis 2 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Feb 25, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.32
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.030
T;T;.;T
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Benign
0.52
D
LIST_S2
Uncertain
0.88
.;.;D;D
MetaRNN
Benign
0.0063
T;T;T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Uncertain
2.8
M;M;M;M
PhyloP100
0.93
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-2.9
.;.;.;D
REVEL
Benign
0.28
Sift
Benign
0.29
.;.;.;T
Sift4G
Uncertain
0.0030
D;.;D;D
Polyphen
1.0
D;D;.;D
Vest4
0.58
MVP
0.87
MPC
0.64
ClinPred
0.035
T
GERP RS
2.8
Varity_R
0.12
gMVP
0.43
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73429414; hg19: chr17-78172328; API